Bioelastic membranes for topical application of a thromboxane synthetase inhibitor for protection of skin from pressure injury: A preliminary study

Wound Repair and Regeneration

Volumn 12, Issue 4, 2004, Pages 453-460

  Kemppainen, Barbara W ^a   Urry, Dan W ^b,c   Swaim, Steven F ^a   Sartin, Eva A ^a   Gillette, Robert L ^a   Hinkle, Sherri H ^a   Coolman, Shindok L ^a   Luan, Chi Xiang ^c   Xu, Jie ^c  

^a AUBURN UNIVERSITY   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Bioelastics Research Ltd   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; DAZMEGREL; GLYCYLVALYLGLYCYLVALYLPROLINE; POLYMER; THROMBOXANE SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DECUBITUS; DENSITY; DISEASE MODEL; DISEASE SEVERITY; DOG; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; GAMMA IRRADIATION; HISTOPATHOLOGY; LYMPHOCYTE; NEUTROPHIL; NONHUMAN; PELVIC GIRDLE; PLASTER CAST; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN SYNTHESIS; SHEAR STRESS; SKIN ABRASION; SKIN PROTECTION; SKIN ULCER; WOUND DRESSING;

ADMINISTRATION, TOPICAL; ANIMALS; BANDAGES; DOGS; ELASTICITY; ENZYME INHIBITORS; HYPEREMIA; IMIDAZOLES; PRESSURE ULCER; THROMBOXANE-A SYNTHASE;

EID: 3442893806     PISSN: 10671927     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1067-1927.2004.12410.x     Document Type: Article

References (9)

1. Robson MC, Heggers JP. Eicosanoids, cytokines, and free radicles. In: Cohen IK, Diegelmann RF, Linblad WJ, editors. Wound healing: biochemical and clinical aspects. Philadelphia: Saunders, 1992:292-304.
2. Vaughn DM, Swaim SF, Milton JL. Elevation of thromboxane in pressure wounds. Prostag Leukotr Ess 1989;37:45-50.
3. Swaim SF, Vaughn DM, Spalding PJ, Riddell KP, McGuire JA. Evaluation of the dermal effects of casts padding in coaptation casts on dogs. Am J Vet Res 1992;53:1266-72.
4. Cross PE, Dickenson RP, Parry MJ, Randall MJ. Selective thromboxane synthetase inhibitors. 2. 3-(1H-lmidazol-1-ylmetyl)-2-methyl-1H-indole-1- propanoic acid and analogues. J Med Chem 1986;29:1643-50.
5. Swaim SF, Bradley DM, Vaughn DM, Powers RD, Hoffman CE, Beard ML. Evaluation of thromboxane synthetase inhibitor in the prevention of dermal pressure lesions. Wounds 1994;6:74-82.
6. Urry DW, Nicol A, Gowda DC, Hogan LD, McGee A, Williams T, Olson DB, Cox BA. Medical applications of bioelastic materials. In: Gebelein CG, editor. Biotechnological polymers: medical, pharmaceutical and industrial applications. Lancaster, PA: Technomic Publishing 1993;82-103.
7. Urry DW. Elastic biomolecular machines. Sci Am 1995;272:64-9.
8. Urry DW, Parker TM, Reid MC, Gowda DC. Biocompatibility of the bioelastic material, poly (GVGVP) and its gamma-irradiated cross-hnked matrix: summary of generic biological test result. J Bioact Compat Pol 1991;6:263-82.
9. Wang N-Z, Urry DW, Swaim SF, Gillette RL, Hoffman CE, Hinkle SH, Coolman SL, Luan C-X, Xu J, Kemppainen BW. Skin concentrations of thromboxane synthetase inhibitor after topical application with bioelastic membrane. J Vet Pharmacol Therap 2004;27:1-7.